Real-time Engagement for Learning to Effectively Control Type 2 Diabetes

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-24
SponsorUniversity of Pittsburgh

About this trial

This is a clinical trial that includes a run-in period, a 90 day micro-randomized trial, and a 90-day observational period. The goal of this study is to evaluate whether providing paired real time glycemic and health behavior data in a smartphone app leads to better glycemic control among adolescents and young adults with T2D. Glycemic control will be monitored using Continuous Glucose Monitors (CGM), and health behavior data will be collected via a Fitbit activity tracker and a research app (Healthmine). Participants will be prompted to view and reflect on glycemic trends and health behavior data (Fitbit data, logging of diet and medication adherence) during the 90-day micro-randomized trial period, then observed for ongoing use of the Healthmine app and engagement with CGM in the following 90-day observation period.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

type 2 diabetes: negative diabetes autoantibodies, no suspicion for monogenic diabetes

HbA1c ≥7.0%, stable medication use

HbA1c 6.0-6.9% without short-acting insulin, any other stable diabetes medication use

English-speaking (app in English)

Disqualifiers

Current pregnancy

Hydroxyurea use (CGM sensor inaccuracies)

Cognitive impairment or severe psychiatric condition that could interfere with participation in behavioral intervention for diabetes self-management

Current or previously diagnosed eating disorder

Trial design

Design model

Single group

Treatments tested in this trial

  • Focused App Prompt

    Behavioral

    Prompts are designed to develop knowledge and self-efficacy in diabetes-related health behaviors (capability). The paired glycemic and behavior data will provide the opportunity to reflect and to plan diet or exercise for the following day (self-reflective motivation).

  • No App Prompt

    Behavioral

    No app prompts are designed to assess whether health behaviors are affected without being prompted to reflect and change those behaviors related to glycemic control.

  • Outreach for Missing Data

    Behavioral

    For participants randomized to proactive outreach, after 3 or more days of missing CGM data, the study team will reach out to participants by phone and/or text message to troubleshoot and support participants in re-connecting with CGM and apps. For participants randomized to not receive proactive outreach, participants will be instructed to reach out to the study team at their discretion when help is needed related to CGM or app connection.

Treatment groups

100 Participants
are divided into 4 treatment groups
Group A: Physical Activity Focused App PromptExperimental treatment 1 intervention
Group B: Diet Focused App PromptExperimental treatment 1 intervention
Group C: No App PromptExperimental treatment 1 intervention
Group D: Outreach for Missing DataExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Glucose time above 180mg/dL

measured using continuous glucose monitor

Time frame
daily during micro randomized trial, 90 days
2

Mean daily glucose

measured using continuous glucose monitor; mg/dL

Time frame
daily during micro randomized trial, 90 days
3

Maximum daily glucose

measured using continuous glucose monitor; mg/dL

Time frame
daily during micro randomized trial, 90 days
4

Minimum daily glucose

measured using continuous glucose monitor; mg/dL

Time frame
daily during micro randomized trial, 90 days

Secondary outcomes

1

Body Mass Index (BMI)

weight and height will be combined to report BMI in kg/m\^2

Time frame
through study completion, 6 months average
2

Diabetes distress

Measured via Problem Areas in Diabetes Scale (PAID-5). Score ranges from 0-20; a total score of 8 or more indicates possible diabetes related emotional distress.

Time frame
through study completion; 6 months average

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Pittsburgh

Lead sponsor

Dartmouth College

Collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

University of Michigan

Collaborator

San Diego State University

Collaborator

Emory University

Collaborator

This trial is not recruiting at the moment. You can still explore other options: